Perioperative melatonin use

Anaesthesia and Intensive Care

Volumn 39, Issue 2, 2011, Pages 171-181

  Jarratt, J ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Anaesthetic; Melatonin; Premedication

Indexed keywords

ACETYLSALICYLIC ACID; BENZODIAZEPINE; CLONIDINE; FLUVOXAMINE; ISOFLURANE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MESSENGER RNA; MIDAZOLAM; MORPHINE; NALOXONE; NIFEDIPINE; PROPOFOL; RAMELTEON; WARFARIN;

ANALGESIA; ANALGESIC ACTIVITY; ANTINOCICEPTION; ANTIOXIDANT ACTIVITY; ANXIETY; AUTOIMMUNE HEPATITIS; DELIRIUM; DIZZINESS; DROWSINESS; DRUG DOSE COMPARISON; DRUG HALF LIFE; FIBROMYALGIA; GENE EXPRESSION; HEADACHE; HEART FAILURE; HEMORRHAGIC SHOCK; HUMAN; INTENSIVE CARE; IRRITABLE COLON; LIPID PEROXIDATION; MOOD CHANGE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PATIENT SAFETY; PERIOPERATIVE PERIOD; PINEAL BODY; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PREMEDICATION; REPERFUSION; REVIEW; SEDATION; SEIZURE; SEPSIS; SIDE EFFECT; SLEEP; SLEEP DISORDER; STRESS; THERMAL STIMULATION; TRANQUILIZING ACTIVITY;

EID: 79953172277     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1103900205     Document Type: Review

References (137)

1. Konturek SJ, Konturek PC, Brzozowski T, Bubenik GA. Role of melatonin in upper gastrointestinal tract. J Physiol Pharmacol 2007; 58:23-52.
2. Zawilska JB, Nowak JZ. Regulatory mechanisms in melatonin biosynthesis in retina. Neurochem Int 1992; 20:23-36.
3. Launay JM, Lamaitre BJ, Husson HP, Dreux C, Hartmann L, Da Prada M. Melatonin synthesis by rabbit platelets. Life Sci 1982; 31:1487-1494. (Pubitemid 13249690)
4. Slominski A, Tobin DJ, Zmijewski MA, Wortsman J, Paus R. Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab 2008; 19:17-24.
5. Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc 1958; 80:2587.
6. Tan D-X, Manchester LC, Hardeland R, Lopez-Burillo S, Mayo JC, Sainz RM et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003; 34:75-78.
7. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12:151-180.
8. Klein DC, Coon SL, Roseboom PH, Weller JL, Bernard M, Gastel JA et al. The melatonin rhythm-generating enzyme: molecular regulation of serotonin N-acetyltransferase in the pineal gland. Recent Prog Horm Res 1997; 52:307-357. (Pubitemid 127470216)
9. Pfeffer M, Kuhn R, Krug L, Korf HW, Stehle JH. Rhythmic variation in beta1-adrenergic receptor mRNA levels in the rat pineal gland: circadian and developmental regulation. Eur J Neurosci 1998; 10:2896-2904. (Pubitemid 29073962)
10. Kennaway DJ, Voultsios A. Circadian rhythm of free melatonin in human plasma. J Clin Endocrinol Metab 1998; 83:1013-1015. (Pubitemid 28496485)
11. Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47:2336-2348. (Pubitemid 35205309)
12. Reppert SM, Weaver DR, Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994; 13:1177-1185. (Pubitemid 24372135)
13. Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella JF. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA 1995; 92:8734-8738.
14. Carlberg C. Gene regulation by melatonin. Ann N Y Acad Sci 2000; 917:387-396.
15. Brown GM. Light, melatonin and the sleep-wake cycle. J Psychiatry Neurosci 1994; 19:345-353. (Pubitemid 24352710)
16. Arendt J. Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Rev Reprod 1998; 3:13-22. (Pubitemid 28062305)
17. Waldhauser F, Boepple PA, Schemper M, Mansfield MJ, Crowley WF Jr. Serum melatonin in central precocious puberty is lower than in age-matched prepubertal children. J Clin Endocrinol Metab 1991; 73:793-796. (Pubitemid 21921940)
18. Reiter RJ, Tan DX, Manchester LC, Pilar Terron M, Flores LJ, Koppisepi S. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 2007; 52:11-28.
19. Reiter RJ. The indoleamine melatonin as a free radical scavenger, electron donor, and antioxidant. In vitro and in vivo studies. Adv Exp Med Biol 1996; 398:307-313. (Pubitemid 126426245)
20. Tan DX, Manchester LC, Burkhardt S, Sainz RM, Mayo JC, Kohen R et al. N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001; 15:2294-2296.
21. Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36:1-9. (Pubitemid 38130283)
22. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005; 27:119-130. (Pubitemid 41558444)
23. Urata Y, Honma S, Goto S, Todoroki S, Iida T, Cho S et al. Melatonin induces gamma-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radic Biol Med 1999; 27:838-847. (Pubitemid 29454587)
24. Acuna CD, Escames G, Carazo A, Leon J, Khaldy H, Reiter RJ. Melatonin, mitochondrial homeostasis and mitochondrial-related diseases. Curr Top Med Chem 2002; 2:133-151.
25. Di WL, Kadva A, Johnston A, Silman R. Varying bioavailability of oral melatonin. N Engl J Med 1997; 336:1028-1029.
26. Pardridge WM, Mietus LJ. Transport of albumin-bound melatonin through the blood-brain barrier. J Neurochem 1980; 34:1761-1763.
27. Jones RL, McGeer PL, Greiner AC. Metabolism of exogenous melatonin in schizophrenic and non-schizophrenic volunteers. Clin Chim Acta 1969; 26:281-285.
28. Vakkuri O, Leppaluoto J, Kauppila A. Oral administration and distribution of melatonin in human serum, saliva and urine. Life Sci 1985; 37:489-495. (Pubitemid 15068204)
29. Aldhous M, Franey C, Wright J, Arendt J. Plasma concentrations of melatonin in man following oral absorption of different preparations. Br J Clin Pharmacol 1985; 19:517-521. (Pubitemid 16254595)
30. Waldhauser F, Waldhauser M, Lieberman HR, Deng MH, Lynch HJ, Wurtman RJ. Bioavailability of oral melatonin in humans. Neuroendocrinology 1984; 39:307-313. (Pubitemid 14031912)
31. Iguchi H, Kato KI, Ibayashi H. Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J Clin Endocrinol Metab 1982; 54:1025-1027. (Pubitemid 13243714)
32. Lemoine P, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res 2007; 16:372-380. (Pubitemid 350151283)
33. Jorgensen KM, Witting MD. Does exogenous melatonin improve day sleep or night alertness in emergency physicians working night shifts? Ann Emerg Med 1998; 31:699-704.
34. Mallo C, Zaidan R, Galy G, Vermeulen E, Brun J, Chazot G et al. Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection. Eur J Clin Pharmacol 1990; 38:297-301. (Pubitemid 20137485)
35. Erman M, Seiden D, Zammit G, Sainati S, Zhang J. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Med 2006; 7:17-24. (Pubitemid 43033540)
36. Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G et al. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet 2009; 373:482-491.
37. Millan MJ, Brocco M, Gobert A, Dekeyne A. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology (Berl) 2005; 177:448-458.
38. Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ 2006; 332:385-393.
39. Sheldon SH. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 1998; 351:1254. (Pubitemid 28181974)
40. Leibenluft E, Feldman-Naim S, Turner EH, Wehr TA, Rosenthal NE. Effects of exogenous melatonin administration and withdrawal in five patients with rapid-cycling bipolar disorder. J Clin Psychiatry 1997; 58:383-388.
41. Carman JS, Post RM, Buswell R, Goodwin FK. Negative effects of melatonin on depression. Am J Psychiatry 1976; 133:1181-1186.
42. Hong YG, Riegler JL. Is melatonin associated with the development of autoimmune hepatitis? J Clin Gastroenterol 1997; 25:376-378.
43. Summary of product characteristics of circadin. RAD Neurim Pharmaceuticals Ltd. From http://www.neurim.com/pdf/H-695-PI-en.pdf Accessed October 2010.
44. Wittkowsky AK. A systematic review and inventory of supplement effects on warfarin and other anticoagulants. Thromb Res 2005; 117:81-86. (Pubitemid 41597035)
45. Hartter S, Grozinger M, Weigmann H, Roschke J, Hiemke C. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther 2000; 67:1-6. (Pubitemid 30078381)
46. von Bahr C, Ursing C, Yasui N, Tybring G, Bertilsson L, Rojdmark S. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects - an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. Eur J Clin Pharmacol 2000; 56:123-127. (Pubitemid 30341385)
47. Lusardi P, Piazza E, Fogari R. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study. Br J Clin Pharmacol 2000; 49:423-427. (Pubitemid 30229445)
48. Neubauer DN. A review of ramelteon in the treatment of sleep disorders. Neuropsychiatr Dis Treat 2008; 4:69-79. (Pubitemid 351460981)
49. Waterhouse J, Reilly T, Atkinson G, Edwards B. Jet lag: trends and coping strategies. Lancet 2007; 369:1117-1129. (Pubitemid 46483663)
50. Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev 2002; CD001520.
51. Cardinali DP, Furio AM, Reyes MP, Brusco LI. The use of chronobiotics in the resynchronization of the sleep-wake cycle. Cancer Causes Control 2006; 17:601-609.
52. Cardinali DP, Bortman GP, Liotta G, Perez LS, Albornoz LE, Cutrera RA et al. A multifactorial approach employing melatonin to accelerate resynchronization of sleep-wake cycle after a 12 time-zone westerly transmeridian flight in elite soccer athletes. J Pineal Res 2002; 32:41-46. (Pubitemid 34123755)
53. Buscemi N, Vandermeer B, Pandya R, Hooton N, Tjosvold L, Hartling L et al. Melatonin for treatment of sleep disorders. Evid Rep Technol Assess (Summ) 2004; n/a:1-7.
54. Jan JE, Freeman RD. Melatonin therapy for circadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade? Dev Med Child Neurol 2004; 46:776-782.
55. Reber A, Huber PR, Ummenhofer W, Gurtler CM, Zurschmiede C, Drewe J et al. General anaesthesia for surgery can influence circulating melatonin during daylight hours. Acta Anaesthesiol Scand 1998; 42:1050-1056. (Pubitemid 28478122)
56. Guo X, Kuzumi E, Charman SC, Vuylsteke A. Perioperative melatonin secretion in patients undergoing coronary artery bypass grafting. Anesth Analg 2002; 94:1085-1091. (Pubitemid 34441813)
57. Gogenur I, Ocak U, Altunpinar O, Middleton B, Skene DJ, Rosenberg J. Disturbances in melatonin, cortisol and core body temperature rhythms after major surgery. World J Surg 2007; 31:290-298. (Pubitemid 46183512)
58. Cronin AJ, Keifer JC, Davies MF, King TS, Bixler EO. Melatonin secretion after surgery. Lancet 2000; 356:1244-1245.
59. Karkela J, Vakkuri O, Kaukinen S, Huang W-Q, Pasanen M. The influence of anaesthesia and surgery on the circadian rhythm of melatonin. Acta Anaesthesiol Scand 2002; 46:30-36. (Pubitemid 34208233)
60. McIntyre IM, Norman TR, Burrows GD, Armstrong SM. Alterations to plasma melatonin and cortisol after evening alprazolam administration in humans. Chronobiol Int 1993; 10:205-213. (Pubitemid 23185016)
61. Murphy PJ, Myers BL, Badia P. Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav 1996; 59:133-139.
62. Munoz-Hoyos A, Fernandez-Garcia JM, Molina-Carballo A, Macias M, Escames G, Ruiz-Cosano C et al. Effect of clonidine on plasma ACTH, cortisol and melatonin in children. J Pineal Res 2000; 29:48-53. (Pubitemid 30449701)
63. Demisch L, Demisch K, Nickelsen T. Influence of dexamethasone on nocturnal melatonin production in healthy adult subjects. J Pineal Res 1988; 5:317-322.
64. Stoschitzky K, Sakotnik A, Lercher P, Zweiker R, Maier R, Liebmann P et al. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 1999; 55:111-115. (Pubitemid 29196263)
65. Govitrapong P, Pariyanonth M, Ebadi M. The presence and actions of opioid receptors in bovine pineal gland. J Pineal Res 1992; 13:124-132. (Pubitemid 23036806)
66. Naguib M, Samarkandi AH. Premedication with melatonin: a double-blind, placebo-controlled comparison with midazolam. Br J Anaesth 1999; 82:875-880. (Pubitemid 29245617)
67. Naguib M, Samarkandi AH. The comparative dose-response effects of melatonin and midazolam for premedication of adult patients: a double-blinded, placebo-controlled study. Anesth Analg 2000; 91:473-479. (Pubitemid 30624319)
68. Acil M, Basgul E, Celiker V, Karagoz AH, Demir B, Aypar U. Perioperative effects of melatonin and midazolam premedication on sedation, orientation, anxiety scores and psychomotor performance. Eur J Anaesthesiol 2004; 21:553-557. (Pubitemid 38987989)
69. Naguib M, Samarkandi AH, Moniem MA, Mansour Eel-D, Alshaer AA, Al-Ayyaf HA et al. The effects of melatonin premedication on propofol and thiopental induction doseresponse curves: a prospective, randomized, double-blind study. Anesth Analg 2006; 103:1448-1452. (Pubitemid 44949212)
70. Samarkandi A, Naguib M, Riad W, Thalaj A, Alotibi W, Aldammas F et al. Melatonin vs. midazolam premedication in children: a double-blind, placebo-controlled study. Eur J Anaesthesiol 2005; 22:189-196. (Pubitemid 40694732)
71. Isik B, Baygin O, Bodur H. Premedication with melatonin vs midazolam in anxious children. Paediatr Anaesth 2008; 18:635-641. (Pubitemid 351777485)
72. Kain ZN, MacLaren JE, Herrmann L, Mayes L, Rosenbaum A, Hata J et al. Preoperative melatonin and its effects on induction and emergence in children undergoing anesthesia and surgery. Anesthesiology 2009; 111:44-49.
73. Capuzzo M, Zanardi B, Schiffino E, Buccoliero C, Gragnaniello D, Bianchi S et al. Melatonin does not reduce anxiety more than placebo in the elderly undergoing surgery. Anesth Analg 2006; 103:121-123. (Pubitemid 44036044)
74. Turkistani A, Abdullah KM, Al-Shaer AA, Mazen KF, Alkatheri K. Melatonin premedication and the induction dose of propofol. Eur J Anaesthesiol 2007; 24:399-402. (Pubitemid 46682418)
75. Evagelidis P, Paraskeva A, Petropoulos G, Staikou C, Fassoulaki A. Melatonin premedication does not enhance induction of anaesthesia with sevoflurane as assessed by bispectral index monitoring. Singapore Med J 2009; 50:78-81.
76. Budhiraja S, Singh J. Adjuvant effect of melatonin on anesthesia induced by thiopental sodium, ketamine, and ether in rats. Methods Find Exp Clin Pharmacol 2005; 27:697-699. (Pubitemid 43266854)
77. Ismail SA, Mowafi HA. Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia. Anesth Analg 2009; 108:1146-1151.
78. Wassmer E, Fogarty M, Page A, Johnson K, Quin E, Seri S et al. Melatonin as a sedation substitute for diagnostic procedures: MRI and EEG. Dev Med Child Neurol 2001; 43:136. (Pubitemid 32170856)
79. Johnson K, Page A, Williams H, Wassemer E, Whitehouse W. The use of melatonin as an alternative to sedation in uncooperative children undergoing an MRI examination. Clin Radiol 2002; 57:502-506. (Pubitemid 35023879)
80. Sury MRJ, Fairweather K. The effect of melatonin on sedation of children undergoing magnetic resonance imaging. Br J Anaesth 2006; 97:220-225. (Pubitemid 44295709)
81. Naguib M, Hammond DL, Schmid PG 3rd, Baker MT, Cutkomp J, Queral L et al. Pharmacological effects of intravenous melatonin: comparative studies with thiopental and propofol. Br J Anaesth 2003; 90:504-507. (Pubitemid 36432443)
82. Naguib M, Schmid PG 3rd, Baker MT. The electroencephalographic effects of IV anesthetic doses of melatonin: comparative studies with thiopental and propofol. Anesth Analg 2003; 97:238-243.
83. Naguib M, Baker MT, Spadoni G, Gregerson M. The hypnotic and analgesic effects of 2-bromomelatonin. Anesth Analg 2003; 97:763-768.
84. Coloma FM, Niles LP. Melatonin enhancement of [3H]-gamma-aminobutyric acid and [3H]muscimol binding in rat brain. Biochem Pharmacol 1988; 37:1271-1274. (Pubitemid 18089470)
85. Niles LP, Pickering DS, Arciszewski MA. Effects of chronic melatonin administration on GABA and diazepam binding in rat brain. J Neural Transm 1987; 70:117-124.
86. Rosenstein RE, Cardinali DP. Melatonin increases in vivo GABA accumulation in rat hypothalamus, cerebellum, cerebral cortex and pineal gland. Brain Res 1986; 398:403-406. (Pubitemid 17210190)
87. Golombek DA, Escolar E, Cardinali DP. Melatonin-induced depression of locomotor activity in hamsters: time-dependency and inhibition by the central-type benzodiazepine antagonist Ro 15-1788. Physiol Behav 1991; 49:1091-1097.
88. Pierrefiche G, Zerbib R, Laborit H. Anxiolytic activity of melatonin in mice: involvement of benzodiazepine receptors. Res Commun Chem Pathol Pharmacol 1993; 82:131-142.
89. Naguib M, Gottumukkala V, Goldstein PA. Melatonin and anesthesia: a clinical perspective. J Pineal Res 2007; 42:12-21. (Pubitemid 44929440)
90. Mowafi HA, Ismail SA. Melatonin improves tourniquet tolerance and enhances postoperative analgesia in patients receiving intravenous regional anesthesia. Anesth Analg 2008; 107:1422-1426.
91. Caumo W, Torres F, Moreira NL Jr, Auzani JAS, Monteiro CA, Londero G et al. The clinical impact of preoperative melatonin on postoperative outcomes in patients undergoing abdominal hysterectomy. Anesth Analg 2007; 105:1263-1271. (Pubitemid 350303928)
92. Caumo W, Levandovski R, Hidalgo MPL. Preoperative anxiolytic effect of melatonin and clonidine on postoperative pain and morphine consumption in patients undergoing abdominal hysterectomy: a double-blind, randomized, placebo-controlled study. J Pain 2009; 10:100-108.
93. Reiter RJ, Acuna-Castroviejo D, Tan D. Melatonin therapy in fibromyalgia. Curr Pain Headache Rep 2007; 11:339-342. (Pubitemid 47505864)
94. Song GH, Leng PH, Gwee KA, Moochhala SM, Ho KY. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut 2005; 54:1402-1407. (Pubitemid 41375196)
95. Lakin ML, Miller CH, Stott ML, Winters WD. Involvement of the pineal gland and melatonin in murine analgesia. Life Sci 1981; 29:2543-2551. (Pubitemid 12169501)
96. Jeong JH, Choi KB, Yi BC, Chun CH, Sung KY, Sung JY et al. Effects of extremely low frequency magnetic fields on pain thresholds in mice: roles of melatonin and opioids. J Auton Pharmacol 2000; 20:259-264. (Pubitemid 34209008)
97. Yu CX, Zhu B, Xu SF, Cao XD, Wu GC. The analgesic effects of peripheral and central administration of melatonin in rats. Eur J Pharmacol 2000; 403:49-53.
98. Pang CS, Tsang SF, Yang JC. Effects of melatonin, morphine and diazepam on formalin-induced nociception in mice. Life Sci 2001; 68:943-951. (Pubitemid 32168069)
99. El-Shenawy SM, Abdel-Salam OME, Baiuomy AR, El-Batran S, Arbid MS. Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat. Pharmacol Res 2002; 46:235-243. (Pubitemid 35300762)
100. Mantovani M, Pertile R, Calixto JB, Santos ARS, Rodrigues ALS. Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway. Neurosci Lett 2003; 343:1-4. (Pubitemid 36577198)
101. Ambriz-Tututi M, Granados-Soto V. Oral and spinal melatonin reduces tactile allodynia in rats via activation of MT2 and opioid receptors. Pain 2007; 132:273-280. (Pubitemid 350064422)
102. Ulugol A, Dokmeci D, Guray G, Sapolyo N, Ozyigit F, Tamer M. Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: possible involvements of the L-arginine-NO pathway and opioid system. Life Sci 2006; 78:1592-1597. (Pubitemid 43259467)
103. Yu CX, Zhu CB, Xu SF, Cao XD, Wu GC. Selective MT(2) melatonin receptor antagonist blocks melatonin-induced antinociception in rats. Neurosci Lett 2000; 282:161-164.
104. Hernandez-Pacheco A, Araiza-Saldana CI, Granados-Soto V, Mixcoatl-Zecuatl T. Possible participation of the nitric oxide-cyclic GMP-protein kinase G-K+ channels pathway in the peripheral antinociception of melatonin. Eur J Pharmacol 2008; 596:70-76.
105. Shavali S, Ho B, Govitrapong P, Sawlom S, Ajjimaporn A, Klongpanichapak S et al. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res Bull 2005; 64:471-479. (Pubitemid 40082497)
106. Li B, Zhang H, Akbar M, Kim HY. Negative regulation of cytosolic phospholipase A(2) by melatonin in the rat pineal gland. Biochem J 2000; 351:709-716.
107. Reiter RJ, Tan DX, Manchester LC, Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001; 34:237-256. (Pubitemid 33615836)
108. Hanania M, Kitain E. Melatonin for treatment and prevention of postoperative delirium. Anesth Analg 2002; 94:338-339. (Pubitemid 34106824)
109. Shigeta H, Yasui A, Nimura Y, Machida N, Kageyama M, Miura M et al. Postoperative delirium and melatonin levels in elderly patients. Am J Surg 2001; 182:449-454. (Pubitemid 34062839)
110. Balan S, Leibovitz A, Zila SO, Ruth M, Chana W, Yassica B et al. The relation between the clinical subtypes of delirium and the urinary level of 6-SMT. J Neuropsychiatry Clin Neurosci 2003; 15:363-366. (Pubitemid 36999381)
111. Rooij SE. The effects of melatonin in the treatment of delirium - a double blind, randomized, placebo-controlled trial. Netherlands Trial Register; NTR1657. From http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1657 Accessed September 2010.
112. Sewerynek E, Melchiorri D, Chen L, Reiter RJ. Melatonin reduces both basal and bacterial lipopolysaccharide-induced lipid peroxidation in vitro. Free Radic Biol Med 1995; 19:903-909.
113. Crespo E, Macias M, Pozo D, Escames G, Martin M, Vives F et al. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 1999; 13:1537-1546. (Pubitemid 29411787)
114. Leon J, Escames G, Rodriguez MI, Lopez LC, Tapias V, Entrena A et al. Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5- methoxykynuramine, a brain metabolite of melatonin. J Neurochem 2006; 98:2023-2033. (Pubitemid 44298263)
115. Reynolds FD, Dauchy R, Blask D, Dietz PA, Lynch D, Zuckerman R. The pineal gland hormone melatonin improves survival in a rat model of sepsis/shock induced by zymosan A. Surgery 2003; 134:474-479. (Pubitemid 37215153)
116. Wu CC, Chiao CW, Hsiao G, Chen A, Yen MH. Melatonin prevents endotoxin-induced circulatory failure in rats. J Pineal Res 2001; 30:147-156. (Pubitemid 32245285)
117. Sener G, Toklu H, Kapucu C, Ercan F, Erkanli G, Kacmaz A et al. Melatonin protects against oxidative organ injury in a rat model of sepsis. Surg Today 2005; 35:52-59. (Pubitemid 40941131)
118. Escames G, Acuna-Castroviejo D, Lopez LC, Tan D, Maldonado MD, Sanchez-Hidalgo M et al. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J Pharm Pharmacol 2006; 58:1153-1165. (Pubitemid 44335028)
119. Escames G, Lopez LC, Ortiz F, Lopez A, Garcia JA, Ros E et al. Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice. FEBS J 2007; 274:2135-2147. (Pubitemid 46588010)
120. Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001; 50:756-760. (Pubitemid 33121647)
121. Fujimoto T, Nakamura T, Ikeda T, Takagi K. Potent protective effects of melatonin on experimental spinal cord injury. Spine (Phila Pa 1976) 2000; 25:769-775.
122. Korkmaz A, Oyar EO, Kardes O, Omeroglu S. Effects of melatonin on ischemic spinal cord injury caused by aortic cross clamping in rabbits. Curr Neurovasc Res 2008; 5:46-51. (Pubitemid 351302654)
123. Guizar-Sahagun G, Rodriguez-Balderas CA, Franco-Bourland RE, Martinez-Cruz A, Grijalva I, Ibarra A et al. Lack of neuroprotection with pharmacological pretreatment in a paradigm for anticipated spinal cord lesions. Spinal Cord 2009; 47:156-160.
124. Maldonado MD, Murillo-Cabezas F, Terron MP, Flores LJ, Tan DX, Manchester LC et al. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res 2007; 42:1-11. (Pubitemid 44924321)
125. Cheung RT. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003; 34:153-160. (Pubitemid 36356840)
126. Ceyran H, Narin F, Narin N, Akgun H, Ceyran AB, Ozturk F et al. The effect of high dose melatonin on cardiac ischemia-reperfusion injury. Yonsei Med J 2008; 49:735-741.
127. Petrosillo G, Colantuono G, Moro N, Ruggiero FM, Tiravanti E, Di Venosa N et al. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol 2009; 297:H1487-1493.
128. Szarszoi O, Asemu G, Vanecek J, Ost'adal B, Kolar F. Effects of melatonin on ischemia and reperfusion injury of the rat heart. Cardiovasc Drugs Ther 2001; 15:251-257.
129. Rodriguez-Reynoso S, Leal C, Portilla-de Buen E, Castillo JC, Ramos-Solano F. Melatonin ameliorates renal ischemia/reperfusion injury. J Surg Res 2004; 116:242-247. (Pubitemid 38180474)
130. Kurcer Z, Oguz E, Ozbilge H, Baba F, Aksoy N, Celik H et al. Melatonin protects from ischemia/reperfusion-induced renal injury in rats: this effect is not mediated by proinflammatory cytokines. J Pineal Res 2007; 43:172-178. (Pubitemid 47077220)
131. Rodriguez-Reynoso S, Leal C, Portilla E, Olivares N, Muniz J. Effect of exogenous melatonin on hepatic energetic status during ischemia/reperfusion: possible role of tumor necrosis factor-alpha and nitric oxide. J Surg Res 2001; 100:141-149. (Pubitemid 32989353)
132. Kazez A, Demirbag M, Ustundag B, Ozercan IH, Saglam M. The role of melatonin in prevention of intestinal ischemiareperfusion injury in rats. J Pediatr Surg 2000; 35:1444-1448.
133. Li Z, Nickkholgh A, Yi X, Bruns H, Gross M-L, Hoffmann K et al. Melatonin protects kidney grafts from ischemia/reperfusion injury through inhibition of NF-kB and apoptosis after experimental kidney transplantation. J Pineal Res 2009; 46:365-372.
134. Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev 2005; 9:25-39. (Pubitemid 40092916)
135. Shilo L, Dagan Y, Smorjik Y, Weinberg U, Dolev S, Komptel B et al. Effect of melatonin on sleep quality of COPD intensive care patients: a pilot study. Chronobiol Int 2000; 17:71-76. (Pubitemid 30078522)
136. Ibrahim MG, Bellomo R, Hart GK, Norman TR, Goldsmith D, Bates S et al. A double-blind placebo-controlled randomised pilot study of nocturnal melatonin in tracheostomised patients. Crit Care Resusc 2006; 8:187-191.
137. Bourne RS, Mills GH, Minelli C. Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial. Crit Care 2008; 12:R52.